MERTK and liver disorder: In conclusion, MERTK rs4374383 A carriers had a lower risk of liver fibrosis progression than G carriers, supporting the hypothesis that this SNP seems to possess a critical role in the pathogenesis of liver disease in HCV-infected patients.